Skip to main content

1-9 of 9 results for subject:Patients

Member X
Lord Bethell
Subject X
Marketing

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

More
Marketing (9)

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

My Lords, I thank all those involved in this first group; indeed, they are the team who, I feel, are likely to be walking with us through a great many groups of amendments. I enormously regret the fact that some noble Lords are unable to make this session, but I...

Member
Lord Bethell (Conservative)
Type
Proceeding contributions
Date
19 October 2020
Reference
806 cc327-9GC
House
House of Lords

My Lords, I hear the noble Lord, Lord Patel, very clearly. The arguments that he made during our conversations and engagement earlier were powerful. The comments made by my noble friends Lord Lansley and Lord O’Shaughnessy, one of whom is my predecessor and one of whom is a former Health...

Member
Lord Bethell (Conservative)
Type
Proceeding contributions
Date
19 October 2020
Reference
806 c330GC
House
House of Lords

Moved by

Lord Bethell

2: Page 1, line 6, at end insert—

“(1A) The appropriate authority may only make regulations under subsection (1) if satisfied that they would promote the health and safety of the public.”

Member’s explanatory statement

This amendment provides that the appropriate authority may only make regulations under subsection (1) of Clause...

Member
Lord Bethell (Conservative)
Type
Proceeding contributions
Date
19 October 2020
Reference
806 c331GC
House
House of Lords

My Lords, Amendments 2, 7, 51, 54, 56, 68 and 72 are a package intended to respond to the comments made at Second Reading and the consideration of the Bill by your Lordships’ Delegated Powers and Regulatory Reform Committee and the Constitution Committee.

I have said at both the Dispatch Box...

Member
Lord Bethell (Conservative)
Type
Proceeding contributions
Date
19 October 2020
Reference
806 cc331-2GC
House
House of Lords

My Lords, I am enormously grateful to my noble friend Lord Lansley and the noble and learned Lord, Lord Woolf, for Amendments 5 and 70. I greatly appreciate their scrutiny and contribution on the way in which regulations under the Bill might be made. I am grateful to my noble...

Member
Lord Bethell (Conservative)
Type
Proceeding contributions
Date
19 October 2020
Reference
806 cc341-2GC
House
House of Lords

I would be happy to conduct that follow-up.

Member
Lord Bethell (Conservative)
Type
Proceeding contributions
Date
19 October 2020
Reference
806 c343GC
House
House of Lords

My Lords, as the Minister for Innovation, I am very keen on the UK’s continued leadership in this area; I have made it something of a personal cause. I am very proud of the fact that the MHRA approves around 950 medicinal trials a year, over half of which are...

Member
Lord Bethell (Conservative)
Type
Proceeding contributions
Date
19 October 2020
Reference
806 cc357-360GC
House
House of Lords

My Lords, I will be happy to write to the noble Lord with the precise figures for phase 3 trials. However, he is right that they are incredibly important. The Bill must defend our position on phase 3 trials, which are very much the sharp end of the clinical trials...

Member
Lord Bethell (Conservative)
Type
Proceeding contributions
Date
19 October 2020
Reference
806 cc358-361GC
House
House of Lords

Moved by

Lord Bethell

7: Page 1, line 7, leave out “making regulations under subsection (1)” and insert “considering whether they would”

Member’s explanatory statement

This amendment requires the appropriate authority to have regard to the factors mentioned in subsection (2)(a), (b) and (c) of Clause 1 in considering whether regulations made under subsection...

Member
Lord Bethell (Conservative)
Type
Proceeding contributions
Date
19 October 2020
Reference
806 c379GC
House
House of Lords